Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Pliant Therapeutics (PLRX) Assets Average (2020 - 2026)

Pliant Therapeutics has reported Assets Average over the past 7 years, most recently at $213.9 million for Q1 2026.

  • Quarterly Assets Average fell 42.32% to $213.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $213.9 million through Mar 2026, down 42.32% year-over-year, with the annual reading at $311.1 million for FY2025, 31.56% down from the prior year.
  • Assets Average was $213.9 million for Q1 2026 at Pliant Therapeutics, down from $250.9 million in the prior quarter.
  • Over five years, Assets Average peaked at $586.4 million in Q2 2023 and troughed at $190.8 million in Q2 2022.
  • The 5-year median for Assets Average is $370.9 million (2025), against an average of $384.8 million.
  • Year-over-year, Assets Average soared 207.3% in 2023 and then crashed 42.32% in 2026.
  • A 5-year view of Assets Average shows it stood at $363.9 million in 2022, then surged by 44.63% to $526.3 million in 2023, then decreased by 19.95% to $421.3 million in 2024, then tumbled by 40.44% to $250.9 million in 2025, then fell by 14.75% to $213.9 million in 2026.
  • Per Business Quant, the three most recent readings for PLRX's Assets Average are $213.9 million (Q1 2026), $250.9 million (Q4 2025), and $288.2 million (Q3 2025).